Keyphrases
Ovarian Cancer
100%
Microenvironment
96%
Raman Spectroscopy
96%
Tumor
77%
Autoreactive T Cells
72%
Tumor-infiltrating Lymphocytes
68%
Morpho-molecular
64%
T Cell Subsets
64%
Adoptive Cell Therapy
64%
Optical Coherence Tomography
64%
Probe-based
64%
Bladder Cancer
40%
Multiple Reference Optical Coherence Tomography
32%
Localized Prostate Cancer
32%
Primary Renal Cell Carcinoma
32%
Randomized Controlled Trial
32%
Metastatic Ovarian Cancer
32%
Cell Infiltration
32%
Natural Killer Cells
32%
Kaposi Sarcoma
32%
Hematoma
32%
Exercise Training
32%
Funding Information
32%
Signal Correlation
32%
Tumor Immune Microenvironment
32%
In Vivo Detection
32%
Tissue Characterization
32%
Squamous Cell Carcinoma (SqCC)
32%
Disease Progression
32%
Molecular Signaling
32%
Non-muscle Invasive Bladder Cancer (NMIBC)
32%
Tumor Diagnosis
32%
Recurrent Tumor
32%
High-risk Human Papillomavirus (HR-HPV)
32%
Bladder
32%
Model Prediction
32%
Imaging Probe
32%
Upper Tract Urothelial Carcinoma
32%
Renal Cell Carcinoma
32%
Image Interpretation
32%
T Cell Response
32%
Clinical Diagnosis
32%
Tissue Heterogeneity
32%
Metastatic Melanoma
28%
HIV-negative
21%
Bladder Tumor
21%
Programmed Death-ligand 1 (PD-L1)
20%
Risk Factors
19%
P16INK4a
18%
Optical Fiber Probe
17%
Medicine and Dentistry
Ovarian Cancer
96%
Neoplasm
94%
Raman Spectrometry
64%
Ex Vivo
53%
Malignant Neoplasm
47%
Bladder Cancer
35%
Randomized Controlled Trial
32%
Bladder Tissue
32%
Cell Therapy
32%
Cellular Infiltration
32%
Natural Killer Cell
32%
Non Muscle Invasive Bladder Cancer
32%
Tumor Infiltrating Lymphocyte
32%
Exercise
32%
Kaposi Sarcoma
32%
T Cell Subset
32%
Hematoma
32%
Tumor Immune Microenvironment
32%
Prostate Cancer
32%
Optical Coherence Tomography
32%
Tumor Diagnosis
32%
Tumor Recurrence
32%
Squamous Cell Carcinoma
32%
Wart Virus
32%
Bladder
32%
Human Immunodeficiency Virus
32%
Disease Exacerbation
32%
Diagnosis
24%
Bladder Tumor
21%
Biopsy
16%
Bladder Biopsy
16%
Disease
14%
Immunohistochemistry
13%
Gene Expression
12%
Primary Tumor
12%
Immunosuppressive Drug
12%
Krukenberg Tumor
12%
Immunity
12%
T Cell
12%
Bladder Pathology
10%
Grading (Tumors)
10%
Fiber Optics
10%
Immunocompromised Patient
10%
Basal-Cell Carcinoma
10%
Scalp
10%
Skin Cancer
10%
High Intensity Interval Training
10%
Health Hazard
10%
Neck
10%
Bladder Perforation
10%
